Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nondisjunction01:21

Nondisjunction

3.7K
Nondisjunction is the failure of homologous chromosomes or sister chromatids to separate correctly and move to the opposite poles of the cells. This produces daughter cells with abnormal chromosome numbers.  Nondisjunction is common during anaphase I or anaphase II of meiosis.  Mutations in synaptonemal complex proteins that attach homologous chromosomes increase the chances of nondisjunction in anaphase I of meiosis I. In contrast, mutations in topoisomerases and condensins that hold...
3.7K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

11.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.7K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer02:18

Cancer

47.3K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
47.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MXene-Based Electrodes for Flexible Supercapacitors: From Material Synthesis to Device Integration.

Materials (Basel, Switzerland)Ā·2026
Same author

CD4<sup>+</sup> Tregs Drive Post-Ischemic Sprouting Angiogenesis via Endothelial YY1/MAML1 Reactivation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)Ā·2026
Same author

Aneuploidy of chromosome 8 promotes the mesenchymal lineage during cell fate transitions.

Science advancesĀ·2026
Same author

Dysregulation of the ALDH1A3/PML-RARĪ± axis promotes the progression of acute promyelocytic leukemia.

Cancer lettersĀ·2026
Same author

Stevens-Johnson syndrome/toxic epidermal necrolysis induced by tislelizumab: a case report and literature review.

Frontiers in immunologyĀ·2025
Same author

Microneedle-Based Portable Immunosensor for the On-Site Determination of Microcystin-LR without Sample Preparation in Aquatic Products.

Journal of agricultural and food chemistryĀ·2025

Related Experiment Video

Updated: May 23, 2025

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

10.4K

Aneuploidy as a cancer vulnerability.

Jinghui Cao1, Cai Liang1, Hongtao Yu1

  • 1New Cornerstone Science Laboratory, School of Life Sciences, Westlake University, Hangzhou, Zhejiang, China; Westlake Laboratory of Life Sciences and Biomedicine, Hangzhou, Zhejiang, China.

Current Opinion in Cell Biology
|March 7, 2025
PubMed
Summary

Aneuploidy, an abnormal chromosome number, is common in cancer but can harm normal cells. Understanding its complex role in cancer offers new therapeutic strategies.

More Related Videos

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.9K
Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

7.2K

Related Experiment Videos

Last Updated: May 23, 2025

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes
05:22

Generation and Isolation of Cell Cycle-arrested Cells with Complex Karyotypes

Published on: April 13, 2018

10.4K
Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel
08:29

Long-term Live-cell Imaging to Assess Cell Fate in Response to Paclitaxel

Published on: May 14, 2018

9.9K
Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts
10:04

Establishment of Proliferative Tetraploid Cells from Nontransformed Human Fibroblasts

Published on: January 8, 2017

7.2K

Area of Science:

  • Genetics and Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Aneuploidy, the presence of an abnormal number of chromosomes, is a hallmark of many human cancers.
  • While prevalent in cancer, the precise role of aneuploidy in tumorigenesis remains complex and debated.
  • Experimentally induced aneuploidy in non-cancerous cells typically leads to reduced cellular fitness due to stress responses.

Purpose of the Study:

  • To discuss the patterns and consequences of aneuploidy in human cancers.
  • To explore the multifaceted roles of aneuploidy in cancer evolution.
  • To highlight emerging therapeutic strategies targeting aneuploidy as a cancer vulnerability.

Main Methods:

  • Review and synthesis of existing literature on aneuploidy in human cancer.
  • Analysis of patterns and consequences of chromosomal abnormalities in oncogenesis.
  • Examination of recent research on exploiting aneuploidy for cancer treatment.

Main Results:

  • Aneuploidy exhibits diverse patterns and significant consequences across various human cancers.
  • The relationship between aneuploidy and cancer progression is complex, involving both promoting and detrimental effects.
  • Aneuploidy can be leveraged as a vulnerability in cancer cells, distinct from its effects in normal cells.

Conclusions:

  • A deeper molecular understanding of aneuploidy's role in cancer is crucial for developing novel therapies.
  • Targeting aneuploidy represents a promising frontier in cancer treatment, exploiting cancer-specific vulnerabilities.
  • Future research should focus on precise interventions that exploit aneuploidy in cancer without harming healthy tissues.